Nefecon® (Budesonide) Selectively Reduces Circulating Levels of BAFF (BLyS) and Soluble BCMA and TACI in IgA Nephropathy: FR-OR37

Saved in:
Bibliographic Details
Published in:Journal of the American Society of Nephrology 2020-10, Vol.31 (10S), p.26-26
Main Authors: Molyneux, Karen, Barratt, Jonathan, Wimbury, David H.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1046-6673
DOI:10.1681/ASN.20203110S126b